5 results (0,13641 seconds)

Brand

Merchant

Price (EUR)

Reset filter

Products
From
Shops

Leishmaniasis Biology Control and New Approaches for Its Treatment

The Neurological Treatment for Nearsightedness and Related Vision Problems A Guide to Vision Improvement Based on 30 Years of Research

The Childhood Obesity Epidemic Why Are Our Children Obese—And What Can We Do About It?

The Childhood Obesity Epidemic Why Are Our Children Obese—And What Can We Do About It?

This title includes a number of Open Access chapters. Child obesity is a serious condition that affects children around the world in growing numbers. With obesity comes an increased risk of other chronic diseases as well making it even more important to understand and treat this condition from a variety of angles. This current volume seeks to understand the phenomenon of child obesity and presents a range of viewpoints on its prevalence causes and treatments. The different sections contained within explore the following topics: • The worldwide prevalence of childhood obesity and its growing effect on children• The causes of childhood obesity and the complex interactions of genetic environmental social and medical factors that contribute to its development• Proposed treatments some intervention-based and others that aim to change how food is marketed and sold to youthThis reference volume offers a comprehensive and thorough guide to a field that is rapidly expanding and points to new directions in research and public policy. Edited by a doctor with extensive experience as a researcher writer and medical practitioner The Childhood Obesity Epidemic is an authoritative and easy-to-use reference that provides resources for researchers in the field students and anyone who wishes to gain an overview to this important field of study. | The Childhood Obesity Epidemic Why Are Our Children Obese—And What Can We Do About It?

GBP 82.99
1

Drug Repurposing and Computational Drug Discovery Strategies and Advances

Drug Repurposing and Computational Drug Discovery Strategies and Advances

Drug repurposing is defined as identifying new pharmacological indications from old existing failed investigational already marketed or FDA-approved drugs and prodrugs and applying these new uses in the treatment of diseases other than the drug’s original intended therapeutic use. The application of computational techniques in discovery research not only helps in the development of drugs from leads or existing drug molecules but can also be useful for the repurposing of existing drug candidates. This new volume presents exciting recent advances in drug repurposing and computational approaches for the discovery and development of drugs against certain difficult-to-treat and life-threatening diseases. With contributions from a global team of experts (academicians scientists and researchers) it explores the sophisticated tools and techniques of drug repurposing and computational drug discovery. It delivers valuable information on computational techniques tools and databases being utilized for drug repurposing and for identifying the uses of existing drug candidates on different emerging or deadly diseases. Drug repurposing and computational approaches addressed in the book target the discovery and development of drugs for microbial infections (bacterial fungal viral COVID-19) parasitic diseases and neglected tropical diseases (NTDs) malignant diseases (cancer) inflammatory diseases cardiovascular disorders diabetes and aging and neurological (CNS) disorders. In addition the challenges and regulatory issues encountered in drug repurposing and computational drug discovery programs are looked at offering perspectives for future directions. | Drug Repurposing and Computational Drug Discovery Strategies and Advances

GBP 147.00
1

Mood Dysregulation Beyond the Bipolar Spectrum

Mood Dysregulation Beyond the Bipolar Spectrum

Reflecting the author’s vast clinical experience as a psychiatrist this volume explains why so many people with treatment resistant depression respond to medication used to treat individuals with bipolar disorder. The book also helps to minimize the bipolar stigma by introducing the concept of mood dysregulation. At present people with mood dysregulation are not adequately described on the pages of any diagnostic manual. A cardinal feature of mood dysregulation is dysphoria a negative mood that is poorly understood but mistaken for the negative mood of depression creating diagnostic confusion one of the sources of treatment resistant depression. The author explains that a preponderance of the people she has seen in her practice who have so-called depression have mood disorders with features of bipolar disorder including response to medications typically effective in people with bipolar disorders. Thus these people are research orphans: to this day a paucity of literature exists on this group of individuals. In this volume the author addresses the clinical problems that result from failure to recognize such mood disorders. Key features of the book: Provides a thorough discussion of dysphoria that is not found in other books on the market Proposes a solution to a common and troublesome clinical problem that of misidentified treatment resistant depression Helps to destigmatize the treatments that are most beneficial to those with dysphoria by introducing the concept of mood dysregulation Discusses the etiology of mood disorders with implications for prevention This volume aims to help mental health professionals and patients more accurately recognize negative mood symptoms dysphoria in particular and arrive at more appropriate interventions to improve treatment outcomes for depression. No other book on the market takes up the topic of dysphoria and how its confusion with depression can lead to diagnostic mistakes that in turn lead to treatment failures and so-called treatment resistant depression. | Mood Dysregulation Beyond the Bipolar Spectrum

GBP 52.99
1